Skip to main content
Retour
Watch Compare

LeonaBio, Inc.

Qualité des données : 83%
LONA
Nasdaq Manufacturing Chemicals
9,69 €
▲ 0,15 € (1,57%)
Cap. Boursière: 91,94 M
Prix
9,79 €
Cap. Boursière
91,94 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -45,76 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-359,39%
En dessous de la moyenne du secteur (-53,41%)
ROIC-270,16%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio9,70
Interest CoverageN/A

Valorisation

PE (TTM)
-0,87
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio3,43
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,9 -1,5
P/B 3,4 1,6
ROE % -359,4 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -105,61 M
ROE -359,39% ROA -322,09%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -45,76 M
ROIC -270,16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 9,70
Interest Coverage N/A Asset Turnover N/A
Working Capital 24,24 M Tangible Book Value 26,79 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,87 Forward P/E N/A
P/B Ratio 3,43 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -49,77%
Market Cap 91,94 M Enterprise Value 71,07 M
Per Share
EPS (Diluted TTM) -24,70 Revenue / Share N/A
FCF / Share -4,87 OCF / Share -4,87
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 43,33%
SBC-Adj. FCF -53,34 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -105,61 M -96,94 M -117,67 M -95,64 M -54,85 M
EPS (Diluted) -24,70 -2,52 -3,09 -2,53 —
Gross Profit — — — — —
Operating Income -102,27 M -100,90 M -125,47 M -104,02 M -64,02 M
EBITDA — — — — —
R&D Expenses 17,50 M 70,68 M 93,79 M 61,46 M 42,79 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — 3 000,0
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 92,15 M 58,78 M 160,25 M 258,15 M 332,01 M
Total Liabilities 64,36 M 13,94 M 30,06 M 23,02 M 10,92 M
Shareholders' Equity 27,79 M 44,84 M 130,19 M 235,14 M 321,08 M
Total Debt — — — — —
Cash & Equivalents 69,28 M 48,44 M 90,58 M 95,97 M 110,54 M
Current Assets 89,46 M 54,84 M 154,73 M 207,53 M 260,80 M
Current Liabilities 47,50 M 13,14 M 28,84 M 21,43 M 9,29 M